The medication exerts its therapeutic effects through multiple mechanisms
It does indicate the drug can work very fast and might continue beyond 12 weeks
These findings highlight the need for a balanced, evidence-based approach in prescribing GLP-1RAs and SGLT2is, noting that while SGLT2is practices align with guidelines, theres room to improve GLP-1RA use in high-risk CKD populations [13, 15]
Lippincott Williams and Wilkins, New York, 1999, pp
If you have been at a dose that previously produced noticeable appetite suppression and that effect suddenly disappears, potency loss is a possible explanation
In addition to fatigue, megaloblastic anemia can cause: Dizziness Shortness of breath Weight loss Muscle weakness 2